Published in Liver Int on January 24, 2014
Diabetes mellitus and metformin in hepatocellular carcinoma. World J Gastroenterol (2016) 0.82
Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden. HPB (Oxford) (2016) 0.79
High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma. Medicine (Baltimore) (2015) 0.79
A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2015) 0.75
Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma. Sci Rep (2016) 0.75
The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma. J Cancer (2016) 0.75
Posthepatectomy Liver Failure Affects Long-Term Function After Resection for Hepatocellular Carcinoma. World J Surg (2016) 0.75
Influence of higher BMI for hepatitis B- and C-related hepatocellular carcinomas. Langenbecks Arch Surg (2017) 0.75
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med (2007) 12.62
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology (2008) 4.61
Marginal structural models as a tool for standardization. Epidemiology (2003) 4.52
Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg (2005) 4.13
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology (2006) 3.68
Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol (2008) 2.64
Nocturnal oxygen desaturation correlates with the severity of coronary atherosclerosis in coronary artery disease. Chest (2003) 2.36
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res (2007) 2.29
Regeneration and function of hemiliver graft: right versus left. Surgery (2006) 2.12
High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg (2005) 2.04
Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery (2008) 2.04
Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg (2003) 2.04
Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol (2002) 2.03
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer (2004) 2.03
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91
The vessel sealing system (LigaSure) in hepatic resection: a randomized controlled trial. Ann Surg (2009) 1.87
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg (2007) 1.82
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR Am J Roentgenol (2010) 1.79
Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res (2012) 1.74
Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol (2003) 1.67
Donor complications associated with living donor liver transplantation in Japan. Transplantation (2009) 1.60
Refinement of venous reconstruction using cryopreserved veins in right liver grafts. Liver Transpl (2004) 1.59
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002). Gastric Cancer (2011) 1.58
Living liver donation: preoperative assessment, anatomic considerations, and long-term outcome. Transplantation (2003) 1.57
S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome. Dig Dis Sci (2013) 1.52
Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene (2004) 1.46
Life-threatening veno-occlusive disease after living-related liver transplantation. Transplantation (2003) 1.46
Ultrasonically assisted retrohepatic dissection for a liver hanging maneuver. Ann Surg (2005) 1.46
Left lobe adult-to-adult living donor liver transplantation: Should portal inflow modulation be added? Liver Transpl (2012) 1.45
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC. J Gastroenterol (2010) 1.44
Hepatic arterial anatomy for right liver procurement from living donors. Liver Transpl (2004) 1.44
Evaluation of hepatic venous congestion: proposed indication criteria for hepatic vein reconstruction. Ann Surg (2002) 1.43
Two-stage pancreatojejunostomy in pancreaticoduodenectomy: a retrospective analysis of short-term results. Am J Surg (2008) 1.41
Temporary auxiliary liver transplantation from a living donor to an adult recipient with familial amyloid polyneuropathy. Transplantation (2002) 1.40
Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg (2004) 1.37
Intraoperative fluorescent cholangiography using indocyanine green: a biliary road map for safe surgery. J Am Coll Surg (2008) 1.34
Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery (2009) 1.29
Giant spin Hall effect in perpendicularly spin-polarized FePt/Au devices. Nat Mater (2008) 1.28
Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey. Ann Surg (2014) 1.25
Report of the 16th follow-up survey of primary liver cancer. Hepatol Res (2005) 1.25
Expression of twist and wnt in human breast cancer. Anticancer Res (2005) 1.23
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res (2015) 1.23
Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg (2003) 1.21
Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol (2012) 1.19
A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer (2011) 1.19
Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy. Ann Surg Oncol (2009) 1.19
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START). J Cancer Res Clin Oncol (2013) 1.18
Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma. Ann Surg (2017) 1.16
Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. Intern Med (2010) 1.15
Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg (2009) 1.15
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review. Hepatol Int (2007) 1.13
Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J Gastroenterol (2009) 1.10
MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol (2009) 1.10
Surgical treatment of abdominal wall tumor seeding after percutaneous transhepatic biliary drainage. Am J Surg (2007) 1.10
Sling suspension of the liver in donor operation: a gradual tape-repositioning technique. Transplantation (2003) 1.09
Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines. J Hepatol (2011) 1.09
Pringle's manoeuvre in living donors. Lancet (2002) 1.08
Results of a Japanese multicenter, randomized trial of endoscopic stenting for non-resectable pancreatic head cancer (JM-test): Covered Wallstent versus DoubleLayer stent. Dig Endosc (2011) 1.08
Effects of middle hepatic vein reconstruction on right liver graft regeneration. Transplantation (2003) 1.08
Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. Jpn J Clin Oncol (2004) 1.07
Analysis of factors affecting operating time, postoperative complications, and length of stay for total knee arthroplasty: nationwide web-based survey. J Orthop Sci (2009) 1.05
Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol (2008) 1.05
Protocol-based noninvasive positive pressure ventilation for acute respiratory failure. J Anesth (2010) 1.05
A comparison of error detection rates between the reading aloud method and the double data entry method. Control Clin Trials (2003) 1.04
Enhanced spin accumulation and novel magnetotransport in nanoparticles. Nat Mater (2004) 1.04
Vein reconstruction in modified right liver graft for living donor liver transplantation. Ann Surg (2003) 1.04
Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable? Scand J Gastroenterol (2010) 1.03
Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases. Ann Surg (2010) 1.02
Duct-to-duct biliary reconstruction in adult living-donor liver transplantation. Transplantation (2004) 1.01
Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. Eur J Radiol (2010) 1.01
Paraganglioma of the pancreas: a case report and review of the literature. Pancreas (2008) 1.01
Peritoneovenous shunting for intractable chylous ascites complicated with lymphangioleiomyomatosis. Intern Med (2008) 1.01
Value of prophylactic abdominal drainage in 1269 consecutive cases of elective liver resection. J Hepatobiliary Pancreat Sci (2009) 1.01
The role of surgery in the current treatment of gastric carcinoma. Gastric Cancer (2002) 1.00
Right lateral sector graft in adult living-related liver transplantation. Transplantation (2002) 1.00
Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology (2006) 1.00
Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transplant (2005) 1.00
The source of moving particles in parafoveal capillaries detected by adaptive optics scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci (2012) 1.00
Comparison of Billroth I and Roux-en-Y reconstruction after distal gastrectomy for gastric cancer: one-year postoperative effects assessed by a multi-institutional RCT. Ann Surg Oncol (2012) 0.99
Comparison of perioperative and long-term outcomes of total and proximal gastrectomy for early gastric cancer: a multi-institutional retrospective study. World J Surg (2014) 0.98
Secondary neoplasms after retinoblastoma treatment: retrospective cohort study of 754 patients in Japan. Jpn J Clin Oncol (2010) 0.98
Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment. Dig Dis Sci (2013) 0.98
Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma. Cancer (2002) 0.98